SE420491B - Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer - Google Patents

Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer

Info

Publication number
SE420491B
SE420491B SE7503688A SE7503688A SE420491B SE 420491 B SE420491 B SE 420491B SE 7503688 A SE7503688 A SE 7503688A SE 7503688 A SE7503688 A SE 7503688A SE 420491 B SE420491 B SE 420491B
Authority
SE
Sweden
Prior art keywords
oxadiazol
alkylamines
diaryl
preparing
oxadiazol alkylamines
Prior art date
Application number
SE7503688A
Other languages
English (en)
Other versions
SE7503688L (sv
Inventor
G W Adelstein
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of SE7503688L publication Critical patent/SE7503688L/sv
Publication of SE420491B publication Critical patent/SE420491B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7503688A 1974-04-01 1975-04-01 Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer SE420491B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US456755A US3917615A (en) 1974-04-01 1974-04-01 1,1-Diaryl-1-oxadiazol-alkylamines

Publications (2)

Publication Number Publication Date
SE7503688L SE7503688L (sv) 1975-10-02
SE420491B true SE420491B (sv) 1981-10-12

Family

ID=23814026

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7503688A SE420491B (sv) 1974-04-01 1975-04-01 Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer
SE7503689A SE420492B (sv) 1974-04-01 1975-04-01 Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7503689A SE420492B (sv) 1974-04-01 1975-04-01 Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer

Country Status (26)

Country Link
US (2) US3917615A (sv)
JP (2) JPS5939434B2 (sv)
AR (2) AR206425A1 (sv)
AT (2) AT342045B (sv)
BE (2) BE827323A (sv)
CA (2) CA1053672A (sv)
CH (2) CH614205A5 (sv)
CS (1) CS194718B2 (sv)
DE (2) DE2514229A1 (sv)
DK (2) DK137375A (sv)
EG (1) EG12104A (sv)
ES (2) ES436044A1 (sv)
FI (2) FI63572C (sv)
FR (2) FR2265376B1 (sv)
GB (2) GB1494943A (sv)
HU (1) HU170747B (sv)
IE (2) IE40894B1 (sv)
IL (2) IL46959A (sv)
NL (2) NL7503856A (sv)
NO (2) NO142174C (sv)
OA (1) OA04914A (sv)
PH (1) PH11423A (sv)
PL (1) PL99553B1 (sv)
SE (2) SE420491B (sv)
YU (1) YU39200B (sv)
ZA (2) ZA751193B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003904A (en) * 1974-04-01 1977-01-18 G. D. Searle & Co. Anti-diarrheal oxadiazoles
US4025524A (en) * 1975-04-16 1977-05-24 G. D. Searle & Co. 2-{3-[4-Azatricyclo(4.3.1.13,8)undecan-4-yl]-1,1-diphenylpropyl}-5-methyl-1,3,4-oxadiazole and congeners
US3998832A (en) * 1975-04-16 1976-12-21 G. D. Searle & Co. Anti-diarrheal compounds
US4086227A (en) * 1975-04-16 1978-04-25 G. D. Searle & Co. Novel anti-diarrheal 4-azatricyclo[4.3.1.13,8 ] undecane derivatives
US4057549A (en) * 1975-04-16 1977-11-08 G. D. Searle & Co. Triarylpropyl-azabicyclooctanes
US3996214A (en) * 1976-02-23 1976-12-07 G. D. Searle & Co. 5-(1,1-Diphenyl-4-(cyclic amino) but-2-trans-en-1-yl)-2-alkyl-1,3,4-oxadiazoles and intermediates thereto
US4013668A (en) * 1976-03-10 1977-03-22 G. D. Searle & Co. 5-(1,1-diphenyl-3-(5- or 6-hydroxy-2-azabicyclo(2.2.2)oct-2-yl)propyl)-2-alkyl-1,3,4-oxadiazoles and related compounds
US4012393A (en) * 1976-03-22 1977-03-15 G. D. Searle & Co. 2-[5-(CYCLIC AMINO) ETHYL-10,11-DIHYDRO-5H-dibenzo[a,d]-cyclohepten-5- yl]-5
US4028364A (en) * 1976-07-06 1977-06-07 G. D. Searle & Co. 2-Azabicyclo[2.2.2.]octan-2-yl-diphenyl-alkanones and related compounds
US4053477A (en) * 1976-09-20 1977-10-11 G. D. Searle & Co. 5-(1,1-diphenyl-3-(4-phenylpiperidino)propyl)-2-methyl-1,3,4-oxadiazole and related compounds
US4194045A (en) * 1977-12-27 1980-03-18 G. D. Searle & Co. 1-(3,3-Diaryl-3-oxadiazolalkyl)-4-phenyl-4-piperidinomethanols and related compounds
US4203990A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal 2-substituted quinuclidines
US4203989A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal diaryl-(1-azabicyclo(2.2.2)octan-2-yl)-alkanols and related compounds
US4596801A (en) 1983-03-24 1986-06-24 Chugai Seiyaku Kabushiki Kaisha 4H-3,1-benzoxazine derivatives, process for producing the same and agricultural or horticultural fungicide containing the same
JPS61194917A (ja) * 1985-02-23 1986-08-29 Matsushita Electric Works Ltd 遅れスイツチ
JPS61195022A (ja) * 1985-02-25 1986-08-29 Matsushita Electric Works Ltd 遅れスイツチ
GB8830226D0 (en) * 1988-12-23 1989-02-22 Beecham Group Plc Novel compounds
DK40890D0 (da) * 1990-02-16 1990-02-16 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
US5889038A (en) * 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
BR112013030031A2 (pt) 2011-05-27 2016-09-13 Reliance Ind Ltd hidrólise e esterificação com catalisadores ácidos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141019A (en) * 1964-07-14 Chaohj
US3299044A (en) * 1964-05-13 1967-01-17 Searle & Co Complex n-substituted azabicycloalkanes
FR1469022A (fr) * 1965-12-14 1967-02-10 Chimie Et Synthese De Picardie Nouveaux dérivés oxadiazoliques et leur procédé de préparation
GB1174411A (en) * 1966-03-02 1969-12-17 Aspro Nicholas Ltd Novel Benzothiophen Compounds, Compositions containing them and processes for their manufacture
GB1231829A (sv) * 1968-09-19 1971-05-12
US3720685A (en) * 1970-07-15 1973-03-13 Squibb & Sons Inc 3-amino-5-benzyl-1,2,4-oxadiazoles

Also Published As

Publication number Publication date
HU170747B (sv) 1977-08-28
GB1456943A (en) 1976-12-01
ES436160A1 (es) 1977-02-01
IE40894L (en) 1975-10-01
NL7503856A (nl) 1975-10-03
IL46966A0 (en) 1975-05-22
ES436044A1 (es) 1977-05-01
DK137375A (sv) 1975-10-02
YU39200B (en) 1984-08-31
NL7503849A (nl) 1975-10-03
DK137275A (sv) 1975-10-02
FR2265376A1 (sv) 1975-10-24
ZA751193B (en) 1976-04-28
FI61895C (fi) 1982-10-11
DE2514183A1 (de) 1975-10-09
FI63572C (fi) 1983-07-11
NO142173C (no) 1980-07-09
JPS5939434B2 (ja) 1984-09-22
NO751103L (sv) 1975-10-02
FI750965A (sv) 1975-10-02
IL46959A0 (en) 1975-05-22
NO751104L (sv) 1975-10-02
SE7503688L (sv) 1975-10-02
AU7958475A (en) 1976-09-30
USRE29556E (en) 1978-02-28
PH11423A (en) 1978-01-09
AR206425A1 (es) 1976-07-23
BE827324A (fr) 1975-09-29
AR206341A1 (es) 1976-07-15
CS194718B2 (en) 1979-12-31
FR2265367A1 (sv) 1975-10-24
JPS5936631B2 (ja) 1984-09-05
ZA751986B (en) 1976-06-30
FI63572B (fi) 1983-03-31
CH613964A5 (sv) 1979-10-31
FR2265376B1 (sv) 1980-02-22
FI61895B (fi) 1982-06-30
YU81675A (en) 1982-02-28
JPS50135081A (sv) 1975-10-25
NO142174B (no) 1980-03-31
GB1494943A (en) 1977-12-14
CA1067498A (en) 1979-12-04
FI750966A (sv) 1975-10-02
NO142173B (no) 1980-03-31
AU7958575A (en) 1976-09-30
IE40895L (en) 1975-10-01
OA04914A (fr) 1975-10-31
ATA245275A (de) 1977-07-15
ATA245175A (de) 1977-05-15
US3917615A (en) 1975-11-04
IE40895B1 (en) 1979-09-12
EG12104A (en) 1978-06-30
CA1053672A (en) 1979-05-01
SE7503689L (sv) 1975-10-02
JPS50135086A (sv) 1975-10-25
FR2265367B1 (sv) 1978-07-28
DE2514229A1 (de) 1975-10-09
IL46959A (en) 1978-03-10
NO142174C (no) 1980-07-09
CH614205A5 (sv) 1979-11-15
SE420492B (sv) 1981-10-12
AT342045B (de) 1978-03-10
PL99553B1 (pl) 1978-07-31
IL46966A (en) 1977-11-30
BE827323A (fr) 1975-09-29
AT340916B (de) 1978-01-10
IE40894B1 (en) 1979-09-12

Similar Documents

Publication Publication Date Title
BG26192A3 (bg) Метод за получаване на 3-арилокси-3-фенилпропиламини
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
SE420492B (sv) Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer
SE421919B (sv) Forfarande for framstellning av 2-tetrahydrofurfuryl-6,7-bensomorfaner
SE7508406L (sv) Forfarande for framstellning av polyfenylenoxid.
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
SE403478B (sv) Sett att framstella 2,2,6,6-tetrametyl-4-oxopiperidin
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
BG24539A3 (bg) Метод за получаване на 1-етил- за- субституирани - фенил - декахидроизохинолини
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE417092B (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat
SU589926A3 (ru) Способ получени дауномицинов
SE415475B (sv) Forfarande for framstellning av 4,5-didehydro-pgf?711alfa
BG22387A3 (bg) Метод за получаване на n,n-диалилдихлорацетамид
SE421310B (sv) Forfarande for framstellning av substituerade bensoylpyridiner
CS191954B2 (en) Method of preparing 3-acetoxy-3,7-dimethyl-6-octennitrile
SE423992B (sv) Forfarande for framstellning av 9, 11, 15-trihydroxi-13, 14-dehydroprostaglandiner
BG27083A3 (bg) Метод за получаване на заместени 1-сулфонилбензимидазоли
SE415656B (sv) Forfarande for framstellning av aminderivat av azidofenoler.
SE420600B (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SU522173A1 (ru) Способ получени алкиламинов
SE427032B (sv) Forfarande for framstellning av 4-nitro-n-metylftalimid

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7503688-9

Effective date: 19880822

Format of ref document f/p: F